Skip to main content
Clinical Trials/NL-OMON55916
NL-OMON55916
Not yet recruiting
Not Applicable

Alterations in microcirculatory oxygenation in long-COVID - MICROX long-COVID

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
106
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Long\-COVID patients
  • Age \>\= 18 years, \<65 years
  • Past COVID\-19 diagnosis, based on
  • o Positive PCR
  • o Positive Sars\-Cov2 serology
  • o Positive rapid antigen test
  • o Typical clinical syndrome during the first pandemic wave, when testing was
  • not possible
  • Long\-COVID\-19 diagnosis based on World Health Organisation consensus
  • diagnosis: (\*Post COVID\-19 condition occurs in individuals with a history of

Exclusion Criteria

  • Long\-COVID patients
  • Unable or not willing to provide written informed consent
  • Unable to complete written questionnaires in Dutch
  • Unable to draw blood for study purposes
  • Diagnosis of dementia
  • Active treatment with hyperbaric oxygen treatment during study start
  • Alternative diagnosis that may explain clinical symptoms
  • Suffering from any pre\-existing immune\-driven disease or use of
  • anti\-inflammatory therapy of any kind (including NSAIDs and steroids) during
  • the last 3 months

Outcomes

Primary Outcomes

Not specified

Similar Trials